Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals' Hormone-Free Intrauterine Device

Core Viewpoint - Organon has entered into an agreement to exclusively license global rights to MIUDELLA, a hormone-free copper intrauterine device (IUD) contraceptive from Sebela Pharmaceuticals [1] Company Summary - Organon is a global healthcare company focused on delivering impactful medicines and solutions for a healthier everyday life [1] - The transaction is subject to review under the Hart-Scott-Rodino Antitrust Improvements Act and U.S. Food and Drug Administration regulations [1]